Review Article
Role of Oxidative Stress in the Pathology and Management of Human Tuberculosis
Table 1
Classification of drugs for the treatment of MDR-TB.
| Second-line drug group | Drug type | Specific drugs |
| Group A | Fluoroquinolones | Levofloxacin Moxifloxacin Gatifloxacin |
| Group B | Second-line injectable agents | Amikacin Capreomycin Kanamycin Streptomycin |
| Group C | Other core second-line agents | Ethionamide/prothionamide Cycloserine/terizidone Linezolid Clofazimine |
| Group D | Group D1 | Pyrazinamide Ethambutol High-dose isoniazid |
| Group D | Group D2 | Bedaquiline Delamanid |
| Group D | Group D3 | p-Aminosalicylic acid Imipenem-cilastatin Meropenem Amoxicillin-clavulanate Thioacetazone |
|
|